Literature DB >> 2565895

The DR3(w18),DQw4 haplotype differs from DR3(w17),DQw2 haplotypes at multiple class II loci.

C K Hurley1, P K Gregersen, J Gorski, N Steiner, F M Robbins, R Hartzman, A H Johnson, J Silver.   

Abstract

The polymorphism of HLA class II molecules in man is particularly evident when comparisons between population groups are made. This study describes a DR3 haplotype commonly present in the American black population. Unlike the Northern European population, in which almost all DR3 individuals are DQw2, approximately 50% of DR3-positive American blacks express a DQw4 allelic product. This study characterizes the DR subregion of that haplotype. cDNA sequence analysis has revealed a DR beta gene which differs at several positions from previously described DR3 beta 1 genes. It is postulated that a gene-conversion-like event with a DRw52 beta gene as donor has generated some of these differences. The haplotype carries a DRw52a allele as defined by oligonucleotide hybridization studies. DNA restriction fragment analysis using a family and several unrelated individuals has allowed us to identify DR alpha and beta fragments associated with the DR3(w18),DQw4 haplotype. The most striking observation is that the DR3(w18),DQw4 haplotype differs from DR3(w17),DQw2 haplotypes at multiple class II loci. Several genetic mechanisms including reciprocal recombination, gene conversion, and point mutation were involved in generating the differences between these haplotypes. Once established, the DR3(w18),DQw4 haplotype appears to be relatively stable in the population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565895     DOI: 10.1016/0198-8859(89)90068-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  12 in total

Review 1.  Genetic analysis of susceptibility to type 1 diabetes.

Authors:  J A Todd
Journal:  Springer Semin Immunopathol       Date:  1992

2.  C4B gene polymorphisms among African and African-American HLA-Bw42-DRw18 haplotypes.

Authors:  P A Fraser; Z L Awdeh; P Ronco; S Simon; B Moore; D Fici; D Marcus-Bagley; E J Yunis; C A Alper
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Complotypes in individuals of African origin: frequencies and possible extended MHC haplotypes.

Authors:  P A Fraser; B Moore; R Stein; S Alosco; A H Johnson; D Marcus-Bagley; Z Awdeh; E J Yunis; C A Alper
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

5.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Human monoclonal antibody MP8 detects a supertypic determinant encoded by DPB alleles DPB2.1, DPB3, DPB4.2, DPB8, DPB9, DPB10, and DPB14.

Authors:  O Mazzoleni; A Longo; G Angelini; M Colonna; N Tanigaki; L Delfino; M P Pistillo; L Kun; G B Ferrara
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Sequence analysis and HLA-DR genotyping of a novel HLA-DRw14 allele.

Authors:  F Obata; I Ito; K Ito; A Abe; M Ohkubo; K Onda; Y G Yang; K Watanabe; N Kashiwagi
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

8.  Arg74 in HLA-DRB1 and DRB3 controls a DR3-related epitope.

Authors:  R Sorrentino; C Iannicola; S Costanzi; G Ratti; C Hurley; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups.

Authors:  M A Fernandez-Viña; X J Gao; M E Moraes; J R Moraes; I Salatiel; S Miller; J Tsai; Y P Sun; J B An; Z Layrisse
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

10.  HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls.

Authors:  I Kockum; R Wassmuth; E Holmberg; B Michelsen; A Lernmark
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.